Silo Pharma, Inc. (SILO) Earnings History
Annual and quarterly earnings data from 2011 to 2024
Loading earnings history...
SILO EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
SILO Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 91.9% | -6526.4% | -6092.6% |
| 2023 | 91.9% | -5347.4% | -5132.6% |
| 2022 | 91.9% | -5031.3% | -5420.9% |
| 2021 | 93.0% | -3851.0% | 5477.9% |
| 2020 | - | - | - |
Download Data
Export SILO earnings history in CSV or JSON format
Free sign-in required to download data
Silo Pharma, Inc. (SILO) Earnings Overview
As of May 8, 2026, Silo Pharma, Inc. (SILO) reported trailing twelve-month net income of -$5M, reflecting +0.8% year-over-year growth. The company earned $-0.54 per diluted share over the past four quarters, with a net profit margin of -6092.6%.
Looking at the long-term picture, SILO's historical earnings data spans multiple years. The company achieved its highest annual net income of $4M in fiscal 2021.
Silo Pharma, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including CMPS (-$288M net income), MNMD (-$238M net income), ATAI (-$154M net income, -48464.0% margin), SILO has comparable earnings metrics. Compare SILO vs CMPS →
SILO Earnings vs Peers
Earnings metrics vs comparable public companies
SILO Historical Earnings Data (2011–2024)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$4M | -18.7% | -$5M | $-1.19 | -6092.6% | -6526.4% |
| 2023 | -$4M | +5.3% | -$4M | $-1.20 | -5132.6% | -5347.4% |
| 2022 | -$4M | -200.1% | -$4M | $-1.71 | -5420.9% | -5031.3% |
| 2021 | $4M | +228.5% | -$3M | $1.30 | 5477.9% | -3851.0% |
| 2020 | -$3M | -199.8% | -$2M | $-2.35 | - | - |
| 2019 | -$1M | -4.5% | $-930,403 | $-1.24 | -2497.7% | -2293.4% |
| 2018 | $-969,463 | -371.9% | $-594,242 | $-0.99 | - | - |
| 2017 | $356,536 | +132.0% | $-470,388 | $0.50 | 42.1% | -55.5% |
| 2016 | -$1M | -171.8% | $-393,658 | $-1.11 | - | - |
| 2015 | $-409,498 | -8.8% | $-217,172 | $-0.40 | - | - |
See SILO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SILO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SILO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSILO — Frequently Asked Questions
Quick answers to the most common questions about buying SILO stock.
Is SILO growing earnings?
SILO EPS of $-0.54 reflects slowing growth at +0.8%, below the 5-year CAGR of N/A. TTM net income is $-5M. Expansion rate has moderated.
What are SILO's profit margins?
Silo Pharma, Inc. net margin is -6092.6%, with operating margin at -6526.4%. Below-average margins reflect competitive or cost pressures.
How consistent are SILO's earnings?
SILO earnings data spans 2011-2024. The current earnings trend is +0.8% YoY. Historical data enables comparison across business cycles.